66 Longitudinal effects of elexacaftor-tezacaftor-ivacaftor therapy on airway infection and inflammation in people with cystic fibrosis
Autor: | Schaupp, L., Addante, A., Voller, M., Fentker, K., Bardua, M., Kuppe, A., Duerr, J., Piehler, L., Rohmel, J., Thee, S., Kirchner, M., Ziehm, M., Lauster, D., Haag, R., Gradzielski, M., Stahl, M., Mertins, P., Boutin, S., Graeber, S., Mall, M. |
---|---|
Zdroj: | In Journal of Cystic Fibrosis October 2023 22 Supplement 3:S35-S35 |
Databáze: | ScienceDirect |
Externí odkaz: |